Vanguard Capital Management
SGHT icon

Vanguard Capital Management’s Sight Sciences SGHT Stock Holding History

Vanguard Capital Management’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.53M Buy
1,573,815
+121,125
+8% +$557K ﹤0.01% 2916
2026
Q1 		$5.48M Buy
+1,452,690
New +$7.84M ﹤0.01% 3026

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management's SGHT Position: Q2 2026 in Review

Vanguard Capital Management increased its Sight Sciences (SGHT) stake by 8.3% in Q2 2026, buying an estimated $557K and bringing the position to 1,573,815 shares worth $8.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2916.

Vanguard Capital Management first reported a position in SGHT in Q1 2026 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Vanguard Capital Management held 1,573,815 shares of Sight Sciences worth $8.53M as of Q2 2026.
  • Vanguard Capital Management bought 121,125 Sight Sciences shares in Q2 2026, an estimated $557K.
  • Sight Sciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2916 holding.
  • Vanguard Capital Management first reported a position in Sight Sciences in Q1 2026 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.